FAQ
Log In
Thursday 8th December 2016
News
 › 
 › 

Draft NICE guidance welcomed by BHF

1st April 2010

The British Heart Foundation has welcomed new draft guidance from the National Institute for Health and Clinical Excellence on Dronedarone.

NICE recommends limited use of dronedarone for atrial fibrillation (AF). June Davison, Senior Cardiac Nurse at the BHF, said the organisations supported the committee's conclusion that dronedarone should not be recommended as a first-line anti-arrhythmic drug on the basis of current evidence, but that dronedarone should be available for people who find their existing drug ineffective or cannot tolerate the drug they are prescribed.

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Draft NICE guidance welcomed by BHF
Author: Mark Nicholls
Article Id: 14551
Date Added: 1st Apr 2010

Sources

Medical News Today

Recent Related Articles

New guidance on HIV self-testing issued by WHO

Guidance to protect lone working nurses

Experimental drug could cut heart events in diabetics

Actions

Add to scrapbook
Show Comments
Add comment
Find all related articles

Tags

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2016